Evidence map›Paper›PMID 33824180›Full record

ArticleScience signaling2021

Input-specific regulation of glutamatergic synaptic transmission in the medial prefrontal cortex by mGlu

Zixiu Xiang, Xiaohui Lv, Xin Lin, Daniel E O'Brien, Molly K Altman, Craig W Lindsley, Jonathan A Javitch, Colleen M Niswender, P Jeffrey Conn

Open access · greenAbstract read
In one paragraph

Article in Science signaling, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Molecular pharmacology of mGluMolecular pharmacology · 2026
    Article
  3. Article
  4. Overexpression of mGluMolecular neurobiology · 2025
    Article
  5. Article
  6. mGlu2 Receptors in the Basal Ganglia: A New Frontier in Addiction Therapy.Frontiers in bioscience (Landmark edition) · 2025
    Review
  7. Profiling the Impact of mGluACS chemical neuroscience · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Exploring the activation mechanism of metabotropic glutamate receptor 2.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. GRM7 gene mutations and consequences for neurodevelopment.Pharmacology, biochemistry, and behavior · 2023
    Review
  20. Advances in translating mGluPharmacology, biochemistry, and behavior · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Zixiu XiangDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.ORCID 0000-0002-1678-209X
Xiaohui LvDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.
Xin LinDepartment of Psychiatry, Columbia University, New York, NY 10032, USA.ORCID 0000-0003-1867-1833
Daniel E O'BrienDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.
Molly K AltmanDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.
Craig W LindsleyDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.ORCID 0000-0003-0168-1445
Jonathan A JavitchDepartment of Psychiatry, Columbia University, New York, NY 10032, USA.ORCID 0000-0001-7395-2967
Colleen M NiswenderDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA.ORCID 0000-0001-6009-8212
P Jeffrey ConnDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA. jeff.conn@vanderbilt.edu.ORCID 0000-0003-2363-0323
Vanderbilt University · USNew York Psychoanalytic Society and Institute · US

Funding

Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at VanderbiltP50HD103537 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jeffrey L Neul · 2020 to 2026
$10.3M
FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTOR SUBTYPESR01NS031373 · NINDS · VANDERBILT UNIVERSITY · PI CONN, P JEFFREY · 1993 to 2025
$6.2M
Functions of Metabotropic Glutamate Receptor SubtypesR37NS031373 · NINDS · VANDERBILT UNIVERSITY · PI CONN, P JEFFREY · 2014 to 2020
$3.5M
Development of an mGlu2/4 heterodimer-selective allosteric modulatorR01MH108498 · NIMH · VANDERBILT UNIVERSITY · PI LINDSLEY, CRAIG, NISWENDER, COLLEEN M · 2016 to 2018
$1.5M
Impact of metabotropic glutamate receptor heterodimerization on signaling and pharmacologyR21NS113614 · NINDS · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI JAVITCH, JONATHAN A · 2019 to 2019
$446k
NICHD NIH HHS P50 HD103537NIMH NIH HHS R01 MH108498NINDS NIH HHS R01 NS031373NINDS NIH HHS R21 NS113614NINDS NIH HHS R37 NS031373
6 · The paper itself

Abstract

Metabotropic glutamate receptors (mGluRs) are G protein-coupled receptors that regulate various aspects of central nervous system processing in normal physiology and in disease. They are thought to function as disulfide-linked homodimers, but studies have suggested that mGluRs can form functional heterodimers in cell lines. Using selective allosteric ligands, ex vivo brain slice electrophysiology, and optogenetic approaches, we found that two mGluR subtypes-mGluR2 and mGluR4 (or mGlu

Indexed as

Prefrontal CortexSynaptic TransmissionSynapses

Identifiers

PMID33824180
PMCPMC8279257
OpenAlexW3149997660

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.